Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Condition(s):Solid Tumor; Hematological MalignancyLast Updated:April 13, 2022Recruiting
Include Studies Not Open or Pending
Condition(s):Solid Tumor; Hematological MalignancyLast Updated:April 13, 2022Recruiting
Condition(s):Chronic Heart FailureLast Updated:August 16, 2021Not yet recruiting
Condition(s):Obstructive Hypertrophic Cardiomyopathy (oHCM)Last Updated:March 25, 2024Recruiting
Condition(s):Acute Respiratory Distress Syndrome (ARDS)Last Updated:September 1, 2023Not yet recruiting
Condition(s):Hypotension Drug-InducedLast Updated:February 20, 2024Recruiting
Condition(s):Muscular Dystrophy, DuchenneLast Updated:October 4, 2021Recruiting
Condition(s):Obesity, MorbidLast Updated:June 1, 2023Recruiting
Condition(s):Mitral Valve Prolapse; Ventricular Arrhythmias and Cardiac ArrestLast Updated:January 10, 2023Recruiting
Condition(s):Heart Rate; Coronary Computed Tomography AngiographyLast Updated:May 17, 2022Recruiting
Condition(s):Liver CirrhosisLast Updated:January 23, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.